Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-10-13 Sale |
2023-10-17 4:32 pm |
ANI PHARMACEUTICALS INC | ANIP | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS |
25,000 | $57.96 | $1,449,036 | 1,110,027 (Indirect Direct) |
View |
| 2023-10-02 Sale |
2023-10-03 8:00 pm |
ANI PHARMACEUTICALS INC | ANIP | Gassert Chad SVP - CORP. DEV. & STRATEGY |
20,000 | $56.48 | $1,129,600 | 322,173 (Indirect Direct) |
View |
| 2023-09-15 Sale |
2023-09-19 5:14 pm |
ANI PHARMACEUTICALS INC | ANIP | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS |
50,000 | $61.81 | $3,090,617 | 1,135,027 (Indirect Direct) |
View |
| 2023-09-01 Sale |
2023-09-05 5:06 pm |
ANI PHARMACEUTICALS INC | ANIP | Gassert Chad SVP - CORP. DEV. & STRATEGY |
20,000 | $64.7 | $1,294,000 | 342,173 (Indirect Direct) |
View |
| 2023-08-28 Sale |
2023-08-30 4:29 pm |
ANI PHARMACEUTICALS INC | ANIP | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS |
50,000 | $63.22 | $3,160,750 | 1,185,027 (Indirect Direct) |
View |
| 2023-08-23 Sale |
2023-08-25 4:22 pm |
ANI PHARMACEUTICALS INC | ANIP | Gutwerg Ori SVP, GENERICS |
15,561 | $62.39 | $970,851 | 74,419 (Direct) |
View |
| 2023-08-23 Sale |
2023-08-25 4:17 pm |
ANI PHARMACEUTICALS INC | ANIP | Marken James G. SVP OPS & PROD DEV |
3,932 | $63 | $247,716 | 133,112 (Direct) |
View |
| 2023-08-16 Sale |
2023-08-16 8:00 pm |
ANI PHARMACEUTICALS INC | ANIP | MERIDIAN VENTURE PARTNERS II LP Meridian Venture Partners II GP L.P. Meridian Venture Partners II Co. Brown Robert E. JR 10% Owner |
200,000 | $58.5 | $11,700,000 | 1,819,259 (Direct) |
View |
| 2023-08-14 Sale |
2023-08-16 7:07 pm |
ANI PHARMACEUTICALS INC | ANIP | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS |
50,000 | $61.35 | $3,067,450 | 1,235,027 (Indirect Direct) |
View |
| 2023-08-14 Sale |
2023-08-16 4:24 pm |
ANI PHARMACEUTICALS INC | ANIP | CAREY STEPHEN P. SVP & CFO |
17,639 | $61.37 | $1,082,505 | 155,839 (Direct) |
View |
| 2023-08-14 Sale |
2023-08-15 8:45 pm |
ANI PHARMACEUTICALS INC | ANIP | Pera Antonio R Director |
3,000 | $60.37 | $181,110 | 33,627 (Direct) |
View |
| 2023-08-11 Sale |
2023-08-15 8:39 pm |
ANI PHARMACEUTICALS INC | ANIP | Lalwani Nikhil PRESIDENT & CEO |
68,282 | $58.32 | $3,982,548 | 521,417 (Direct) |
View |
| 2023-08-01 Sale |
2023-08-03 6:03 pm |
ANI PHARMACEUTICALS INC | ANIP | Gassert Chad SVP - CORP. DEV. & STRATEGY |
20,000 | $51.06 | $1,021,200 | 362,173 (Indirect Direct) |
View |
| 2023-07-19 Sale |
2023-07-21 7:15 pm |
ANI PHARMACEUTICALS INC | ANIP | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS |
23,469 | $52.02 | $1,220,844 | 1,285,027 (Indirect Direct) |
View |
| 2023-07-14 Sale |
2023-07-18 8:06 pm |
ANI PHARMACEUTICALS INC | ANIP | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS |
26,531 | $51.02 | $1,353,599 | 1,308,496 (Indirect Direct) |
View |
| 2023-07-03 Sale |
2023-07-06 4:15 pm |
ANI PHARMACEUTICALS INC | ANIP | Gassert Chad SVP - CORP. DEV. & STRATEGY |
20,000 | $53.43 | $1,068,600 | 382,173 (Indirect Direct) |
View |
| 2023-06-20 Sale(A) |
2023-06-23 8:01 pm |
ANI PHARMACEUTICALS INC | ANIP | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS |
50,000 | $51.7 | $2,584,912 | 1,335,027 (Indirect Direct) |
View |
| 2023-06-22 Sale |
2023-06-23 8:00 pm |
ANI PHARMACEUTICALS INC | ANIP | Gassert Chad SVP - CORP. DEV. & STRATEGY |
20,000 | $51.32 | $1,026,400 | 402,173 (Indirect Direct) |
View |
| 2023-06-20 Sale |
2023-06-22 8:00 pm |
ANI PHARMACEUTICALS INC | ANIP | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS |
40,000 | $51.75 | $2,070,012 | 1,345,027 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-09-12 Tax Withholding |
2023-09-14 08:01 am |
N/A N/A |
ANI PHARMACEUTICALS INC | ANIP | Davis Krista SVP, CHIEF HR OFFICER |
1,486 | $61.91 | 35,209 (Direct) |
View |
| 2023-09-08 Tax Withholding |
2023-09-11 6:23 pm |
N/A N/A |
ANI PHARMACEUTICALS INC | ANIP | Lalwani Nikhil PRESIDENT & CEO |
3,646 | $61.94 | 349,744 (Direct) |
View |
| 2023-08-23 Exercise |
2023-08-25 4:22 pm |
N/A 2031-02-15 |
ANI PHARMACEUTICALS INC | ANIP | Gutwerg Ori SVP, GENERICS |
13,502 | $31.49 | 74,419 (Direct) |
View |
| 2023-08-23 Exercise |
2023-08-25 4:17 pm |
N/A 2026-04-06 |
ANI PHARMACEUTICALS INC | ANIP | Marken James G. SVP OPS & PROD DEV |
3,750 | $40.59 | 133,112 (Direct) |
View |
| 2023-08-23 Exercise |
2023-08-25 4:17 pm |
N/A 2024-03-31 |
ANI PHARMACEUTICALS INC | ANIP | Marken James G. SVP OPS & PROD DEV |
1,667 | $33 | 133,112 (Direct) |
View |
| 2023-08-21 Option Award |
2023-08-23 8:44 pm |
N/A N/A |
ANI PHARMACEUTICALS INC | ANIP | Leonard Matthew J Director |
7,583 | $0 | 7,583 (Direct) |
View |
| 2023-08-15 Exercise |
2023-08-15 8:39 pm |
N/A 2030-09-08 |
ANI PHARMACEUTICALS INC | ANIP | Lalwani Nikhil PRESIDENT & CEO |
11,616 | $29 | 521,417 (Direct) |
View |
| 2023-07-18 Tax Withholding |
2023-07-19 7:14 pm |
N/A N/A |
ANI PHARMACEUTICALS INC | ANIP | Cook Meredith SR. VP, GENERAL COUNSEL & SEC. |
1,743 | $51.89 | 37,799 (Direct) |
View |
| 2023-05-23 Option Award |
2023-05-24 4:36 pm |
N/A N/A |
ANI PHARMACEUTICALS INC | ANIP | TANNENBAUM RENEE P Director |
6,865 | $0 | 20,211 (Direct) |
View |
| 2023-05-23 Option Award |
2023-05-24 4:34 pm |
N/A N/A |
ANI PHARMACEUTICALS INC | ANIP | Walsh Patrick D Director |
6,865 | $0 | 70,302 (Direct) |
View |
| 2023-05-23 Option Award |
2023-05-24 4:33 pm |
N/A N/A |
ANI PHARMACEUTICALS INC | ANIP | Thoma Jeanne Director |
6,865 | $0 | 36,199 (Direct) |
View |
| 2023-05-23 Option Award |
2023-05-24 4:32 pm |
N/A N/A |
ANI PHARMACEUTICALS INC | ANIP | Pera Antonio R Director |
6,865 | $0 | 36,627 (Direct) |
View |
| 2023-05-23 Option Award |
2023-05-24 4:31 pm |
N/A N/A |
ANI PHARMACEUTICALS INC | ANIP | NASH DAVID Director |
6,865 | $0 | 38,561 (Direct) |
View |
| 2023-05-23 Option Award |
2023-05-24 4:30 pm |
N/A N/A |
ANI PHARMACEUTICALS INC | ANIP | HAUGHEY THOMAS Director |
6,865 | $0 | 47,116 (Direct) |
View |
| 2023-04-10 Tax Withholding |
2023-04-12 4:43 pm |
N/A N/A |
ANI PHARMACEUTICALS INC | ANIP | CAREY STEPHEN P. SVP & CFO |
4,534 | $38.5 | 173,478 (Direct) |
View |
| 2023-04-10 Tax Withholding |
2023-04-12 4:42 pm |
N/A N/A |
ANI PHARMACEUTICALS INC | ANIP | Marken James G. SVP OPS & PROD DEV |
2,289 | $38.5 | 131,627 (Direct) |
View |
| 2023-02-28 Option Award |
2023-04-06 8:00 pm |
N/A N/A |
ANI PHARMACEUTICALS INC | ANIP | CAREY STEPHEN P. SVP & CFO |
40,526 | $0 | 178,012 (Direct) |
View |
| 2023-02-28 Option Award |
2023-04-04 8:10 pm |
N/A N/A |
ANI PHARMACEUTICALS INC | ANIP | Lalwani Nikhil PRESIDENT & CEO |
159,216 | $0 | 410,056 (Direct) |
View |
| 2023-02-28 Option Award |
2023-04-04 8:08 pm |
N/A N/A |
ANI PHARMACEUTICALS INC | ANIP | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS |
28,947 | $0 | 1,385,027 (Direct) |
View |
| 2023-02-28 Option Award |
2023-04-04 8:07 pm |
N/A N/A |
ANI PHARMACEUTICALS INC | ANIP | Mutz Christopher HEAD OF RARE DISEASE |
28,947 | $0 | 66,607 (Direct) |
View |
| 2023-02-28 Option Award |
2023-04-04 8:06 pm |
N/A N/A |
ANI PHARMACEUTICALS INC | ANIP | Marken James G. SVP OPS & PROD DEV |
21,710 | $0 | 133,916 (Direct) |
View |
| 2023-02-28 Option Award |
2023-04-04 8:04 pm |
N/A N/A |
ANI PHARMACEUTICALS INC | ANIP | Gutwerg Ori SVP, GENERICS |
28,947 | $0 | 62,974 (Direct) |
View |
| 2023-02-28 Option Award |
2023-04-04 8:03 pm |
N/A N/A |
ANI PHARMACEUTICALS INC | ANIP | Gassert Chad SVP - CORP. DEV. & STRATEGY |
28,947 | $0 | 422,173 (Direct) |
View |
| 2023-02-28 Option Award |
2023-04-04 8:01 pm |
N/A N/A |
ANI PHARMACEUTICALS INC | ANIP | Davis Krista SVP, CHIEF HR OFFICER |
20,262 | $0 | 36,695 (Direct) |
View |